✦ LIBER ✦

PCN90 BORTEZOMIB IS COST-EFFECTIVE FOR FIRST-LINE TREATMENT OF MULTIPLE MYELOMA IN SWEDEN

✍ Scribed by JB Rickert; J Hornberger; J Liwing; J Aschan; L Gjönnes; R Dhawan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN48 THE COST-EFFECTIVENESS OF BORTEZOM

✍ JB Rickert; J Hornberger; R Dhawan; J Liwing; J Aschan; M Lothgren 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN65 A COST-EFFECTIVENESS ANALYSIS OF T

✍ KK Lee; VW Lee; KC Kuok 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

NICE guidance on bortezomib and thalidom

✍ Sally Doss; Nicola Hay; Frances Sutcliffe 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 48 KB

PCN90 Cost Effectiveness Analysis of Ben

✍ S. Vandekerckhove; K. Holtzer-Goor; D. Van Den Steen; Y. van Megen; P. Huijgens; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Lenalidomide Is Effective for the Treatm

✍ Ito, Chisako; Aisa, Yoshinobu; Mihara, Ai; Nakazato, Tomonori 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 982 KB

PCN100 COST-EFFECTIVENESS OF GEFITINIB V

✍ J Jacob; M Henriksson; D Brattström 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB